Metformin and contrast media: Where is the conflict?

Canadian Association of Radiologists Journal

Volumn 49, Issue 3, 1998, Pages 161-166

  Rasuli, Pasteur ^a   Hammond, D Ian ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Contrast media; Lactic acidosis; Metformin; Renal failure

Indexed keywords

CONTRAST MEDIUM; METFORMIN;

ARTICLE; CLINICAL PROTOCOL; DIABETES MELLITUS; DOSE KIDNEY FUNCTION RELATION; DRUG WITHDRAWAL; GASTROINTESTINAL TOXICITY; HUMAN; IMAGE ENHANCEMENT; IMAGE INTENSIFIER; KIDNEY FAILURE; LACTIC ACIDOSIS; RISK FACTOR;

EID: 0031821112     PISSN: 00082902     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Dachman AH. New contraindication to intravascular iodinated contrast material (letter). Radiology 1995;197:545.
2. Rotter A. New contraindication to intravascular iodinated contrast material (letter). Radiology 1995; 197:545-6.
3. Schafer G. Biguanides: a review of history, pharmacodynamics and therapy. Diabetes Metab 1983;9: 148-163.
4. Sirtori CR, Pasik C. Re-evaluation of biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 1994;30:187-228.
5. Lucis OJ. The status of metformin in Canada. CMAJ 1983;128:24-6.
6. Lambert H, Isnard F, Delorme N, Claude D, Bollaert PE, Straczek J, et al. Approche physiopathologique des hyperlactémies pathologiques chez diabétique intérêt de la metforminémie. Ann Fr Anesth Reanim 1987;6:88-94.
7. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high low-osmolality iodinated contrast media. Radiology 1993; 188:171-178.
8. Katholi RE, Taylor CJ, McCann WP, et al. Nephrotoxicity from contrast media: attenuation with theophylline. Radiology 1995;195:17-22.
9. Erley CM, Duda SH, Schlepckow S, et al. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 1991;39:539-544.
10. Gandhi MR, Brown P, Ramanowski CAJ, et al. The use of theophylline, an adenosine antagonist in the prevention of contrast medium-induced nephrotoxicity (letter). Br J Radiol 1992;65:838.
11. Rasuli P, French G, Hammond DI. New contraindication to intravascular contrast medium (letter). Radiology 1996;201:289.
12. Dachman AH. New contraindication to intravascular contrast medium (letter). Radiology 1996; 201:289-290.
13. Hayat JC. The treatment of lactic acidosis in the diabetic patient by peritoneal dialysis using sodium acetate. A report of two cases. Diabetologia 1974;10:485-487.
14. Assan. Metformin-induced lactic acidosis in the presence of acute renal failure. Diabetologia 1977;13: 211-217.
15. Prinseau J. Jardin F. Sanchez A, et al. Insuffisance rénale aigüe apres U.I.V. chez le diabétique. Fréquence de l'acidose lactique sous traitement par la metformine. Ann Med Interne 1977;128:173-177.
16. Lalau JD, Westeel PF, Debussche X, et al. Bicarbonate hemodialysis: an adequate treatment for lactic acidosis in diabetics treated by metforrnin. Intensive Care Med 1987;13:383-387.
17. Lalau JD, Andrejak M, Moriniere Ph, et al. Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Clin Pharmacol Ther 1989;6:285-288.
18. Westberg G. Satt ut metformin fore kontrastrontgen. Lakertidningen 1995;92(24):2520.
19. Safadi R, Dranitzki-Elhalel M, Popovtzer M, Ben-Yehuda A. Metformin-induced lactic acidosis associated with acute renal failure. Am J Nephrol 1996;16:520-522.
20. Zanduk E, Demey HE, Bossaert LL. Lactaatacidose door metformine. Tijdschr voor Geneeskunde 1997; 53(8):543-546.
21. Matchett WJ, McFarland DR, Russel DK, Sailors DM, Moursi MM. Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography. Radiology 1996;201:509-571.
22. Kerns SR, Hawkins IF Jr. Carbon dioxide digital subtraction angiography: expanding application and technical evolution. Am J Roentgenol 1995;164:735.